234 related articles for article (PubMed ID: 2273963)
41. Biocompatibility of hemodialysis membranes: a study in healthy subjects.
Gutierrez A; Alvestrand A; Bergström J; Beving H; Lantz B; Henderson LW
Blood Purif; 1994; 12(2):95-105. PubMed ID: 7826580
[TBL] [Abstract][Full Text] [Related]
42. Anaphylatoxin C5a generation and dialysis-induced leukopenia with different hemodialyzer membranes.
Aljama P; Martín-Malo A; Castillo D; Velasco F; Torres A; Pérez R; Castro M
Blood Purif; 1986; 4(1-3):88-92. PubMed ID: 3730166
[TBL] [Abstract][Full Text] [Related]
43. [Results of test-bed and clinical trials of DIP-03-02 dialyzers manufactured by the West German firm Frezenius using polysulfone hollow fibers].
Baeva LB; Poz IaL; Levitskiĭ ER; Pronchenko IA; Tseĭtlina EA; Leonova LN; Mirakova EV
Med Tekh; 1990; (4):40-2. PubMed ID: 2215175
[TBL] [Abstract][Full Text] [Related]
44. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.
Smeby LC; Widerøe TE; Balstad T; Jørstad S
Blood Purif; 1986; 4(1-3):93-101. PubMed ID: 3730167
[TBL] [Abstract][Full Text] [Related]
45. Enhanced biocompatibility with a new cellulosic membrane: Cuprophan versus Hemophan.
Schaefer RM; Hörl WH; Kokot K; Heidland A
Blood Purif; 1987; 5(4):262-7. PubMed ID: 3426830
[TBL] [Abstract][Full Text] [Related]
46. Hemodialysis leukopenia and polymorph random mobility-a possible correlation.
Henderson LW; Miller ME; Hamilton RW; Norman ME
J Lab Clin Med; 1975 Feb; 85(2):191-7. PubMed ID: 803539
[TBL] [Abstract][Full Text] [Related]
47. Dilemma of membrane biocompatibility and reuse.
Klinkmann H; Grassmann A; Vienken J
Artif Organs; 1996 May; 20(5):426-32. PubMed ID: 8725623
[TBL] [Abstract][Full Text] [Related]
48. Anaphylatoxin formation during hemodialysis: comparison of new and re-used dialyzers.
Chenoweth DE; Cheung AK; Ward DM; Henderson LW
Kidney Int; 1983 Dec; 24(6):770-4. PubMed ID: 6609270
[TBL] [Abstract][Full Text] [Related]
49. Hemodialysis-related bioincompatibility and adhesion molecules.
Dhondt A; Vanholder R; Lameire N
Int J Artif Organs; 1998 Sep; 21(9):501-5. PubMed ID: 9828053
[No Abstract] [Full Text] [Related]
50. Haemodialysis leucopenia as an index of membrane biocompatibility.
Aljama P; Garin JM; Torres A; Martin-Malo A; Moreno E; Perez-Calderon R
Contrib Nephrol; 1984; 37():129-33. PubMed ID: 6713865
[No Abstract] [Full Text] [Related]
51. Leukopenia, hypoxia, and complement function with different hemodialysis membranes.
Jacob AI; Gavellas G; Zarco R; Perez G; Bourgoignie JJ
Kidney Int; 1980 Oct; 18(4):505-9. PubMed ID: 7230613
[TBL] [Abstract][Full Text] [Related]
52. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.
Craddock PR; Fehr J; Dalmasso AP; Brighan KL; Jacob HS
J Clin Invest; 1977 May; 59(5):879-88. PubMed ID: 856872
[TBL] [Abstract][Full Text] [Related]
53. Membrane biocompatibility: clinical significance and therapeutic implications.
Dumler F; Levin NW
Int J Artif Organs; 1985 Sep; 8(5):257-62. PubMed ID: 3910591
[No Abstract] [Full Text] [Related]
54. Biocompatibility of haemodialysis membranes.
van Berlo A; Ellens DJ
Adv Exp Med Biol; 1988; 238():341-58. PubMed ID: 3074642
[No Abstract] [Full Text] [Related]
55. Adherence of blood cells to dialyzer membranes as a measure of biocompatibility.
Kjellstrand P; Okmark P; Odselius R; Thysell H; Riede G; Holmquist B
Int J Artif Organs; 1991 Nov; 14(11):698-702. PubMed ID: 1757156
[TBL] [Abstract][Full Text] [Related]
56. Biocompatibility criteria in hemodialysis.
Cordonnier DJ; Forêt M
Contrib Nephrol; 1989; 71():30-5. PubMed ID: 2680263
[No Abstract] [Full Text] [Related]
57. [Activation of complement during hemodialysis].
Nagake Y; Amano T; Wada J; Sugimoto H; Kawabata K; Shikata K; Makino H; Ota Z
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):138-45. PubMed ID: 7553047
[TBL] [Abstract][Full Text] [Related]
58. Effect of chemical germicides on the integrity of hemodialyzer membranes.
Bland LA; Favero MS; Oxborrow GS; Aguero SM; Searcy BP; Danielson JW
ASAIO Trans; 1988; 34(3):172-5. PubMed ID: 3058170
[TBL] [Abstract][Full Text] [Related]
59. In vivo visualization of hemodialysis-induced alterations in leukocyte-endothelial interactions.
Van Teijlingen ME; Borgdorff P; Van Wijhe MH; Van Lambalgen TA; Wee PM; Tangelder GJ
Kidney Int; 2000 Jun; 57(6):2608-17. PubMed ID: 10844631
[TBL] [Abstract][Full Text] [Related]
60. Interleukin 8 and biocompatibility of dialysis membranes.
Niwa T; Miyazaki T; Sato M; Kambe F; Tsuzuki T; Uema K; Maeda K; Seo H
Am J Nephrol; 1995; 15(3):181-5. PubMed ID: 7618641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
